Onyx Biotec (NSE:ONYX) ROCE %: 3.71% (As of Mar. 2026)


NSE:ONYX Onyx Biotec Ltd NSE:ONYX
13 GF Score
Price ₹38.95
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec ROCE %?

Onyx Biotec NSE:ONYX 13 ROCE % is 3.71% as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Onyx Biotec's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.71%.

Onyx Biotec  (NSE:ONYX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Onyx Biotec ROCE % Related Terms

Onyx Biotec ROCE % Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec ROCE % Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
16.08 9.53 14.64 14.45 1.23

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial 0.00 20.03 10.07 -1.17 3.71
NSE:ONYX
13GF Score
Onyx Biotec Ltd NSE:ONYX
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec ROCE % Calculation

Onyx Biotec's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=7.898/( ( (912.479 - 257.284) + (951.546 - 325.27) )/ 2 )
=7.898/( (655.195+626.276)/ 2 )
=7.898/640.7355
=1.23 %

Onyx Biotec's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=23.34/( ( (921.242 - 289.42) + (951.546 - 325.27) )/ 2 )
=23.34/( ( 631.822 + 626.276 )/ 2 )
=23.34/629.049
=3.71 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.71% mean?
Onyx Biotec (NSE:ONYX) has a ROCE % of 3.71% as of Mar. 2026.
Is Onyx Biotec's ROCE % too high?
Onyx Biotec's current ROCE % is 3.71%. The Medical Devices & Instruments industry median ROCE % is 2.23. Onyx Biotec's value of 3.71% is 66.4% above this industry median. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's ROCE % compare to ISRG and BDX?
Onyx Biotec's ROCE % of 3.71% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Onyx Biotec's value of 3.71% is 66.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Biotec's current ROCE % of 3.71% is 66.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current ROCE % is 3.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current ROCE % of 3.71%. The current ROCE % is 3.71% and 66.4% above the Medical Devices & Instruments industry median of 2.23. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current ROCE % is 3.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score

Get the complete analysis for NSE:ONYX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.95
Price